Utility of BMIQ, a novel web-based weight management programme, at an academic weight management centre.

Autor: Barenbaum SR; Comprehensive Weight Control Center, Division of Endocrinology Diabetes, and Metabolism, Weill Cornell Medicine New York New York., Mathews SE; Comprehensive Weight Control Center, Division of Endocrinology Diabetes, and Metabolism, Weill Cornell Medicine New York New York., Saunders KH; Comprehensive Weight Control Center, Division of Endocrinology Diabetes, and Metabolism, Weill Cornell Medicine New York New York., Minero G; BMIQ Greenwich Connecticut., Mauer E; Department of Healthcare Policy and Research Weill Cornell Medicine New York New York., Aronne LJ; Comprehensive Weight Control Center, Division of Endocrinology Diabetes, and Metabolism, Weill Cornell Medicine New York New York., Shukla AP; Comprehensive Weight Control Center, Division of Endocrinology Diabetes, and Metabolism, Weill Cornell Medicine New York New York.
Jazyk: angličtina
Zdroj: Obesity science & practice [Obes Sci Pract] 2019 Dec 04; Vol. 6 (2), pp. 134-138. Date of Electronic Publication: 2019 Dec 04 (Print Publication: 2020).
DOI: 10.1002/osp4.393
Abstrakt: Background: BMIQ is a customizable online platform used to deliver evidence-based behavioural management that complements office visits with healthcare providers. BMIQ offers educational materials, meal plans and tracking tools for patients, and remote monitoring and guidance for physicians. In this retrospective chart review, the implementation and utility of BMIQ was assessed in patients treated at the Comprehensive Weight Control Center (CWCC) at Weill Cornell Medicine.
Methods: The study included all new patients seen at the CWCC between 9/1/2016 and 6/1/2017 who enrolled in BMIQ. Use of BMIQ was assessed by the number of enrolled patients who activated their account and viewed BMIQ sessions. Demographics, comorbidities, medications, and weight change during 6-month follow-up were obtained from the electronic medical records.
Results: Of the 495 new patients enrolled in BMIQ, 217 met the inclusion criteria of 6-month follow-up. The mean age was 50.2 (±13.1) and 72% (n = 157) were female. Sixty-four percent (n = 138) activated their BMIQ account and viewed greater than or equal to 1 BMIQ session. The average number of physician and registered dietitian visits were 3.5 (±1.1) and 1.9 (±1.6), respectively. The average number of weight loss medications was 1.6 with metformin being the most commonly prescribed (76%). Mean weight loss at 6 months was 7.0 ± 5.9%; 59% achieved greater than or equal to 5% weight loss and 28% achieved greater than or equal to 10% weight loss. The total number of physician visits and weight-loss pharmacotherapies used were significant predictors of patients achieving greater than or equal to 5% weight loss. Regular BMIQ usage was an independent predictor of patients achieving both greater than or equal to 5% and greater than or equal to 10% weight loss at 6 months.
Conclusion: Clinically significant weight loss was achieved in the majority of patients with limited in-clinic physician and registered dietitian follow-up in combination with BMIQ. This retrospective study demonstrates the utility of online behavioural therapy as part of a medical weight management intervention.
Competing Interests: Katherine H. Saunders has an ownership and management interest in BMIQ. Guadalupe Minero is an employee of and has an ownership interest in BMIQ. Louis J. Aronne is the founder and CEO of BMIQ. All other authors have declared no conflicts of interest.
(© 2019 The Authors. Obesity Science & Practice published by John Wiley & Sons Ltd, World Obesity and The Obesity Society.)
Databáze: MEDLINE
Externí odkaz: